Introduction
Renal transplantation is the most common solid organ transplantation worldwide. The prevalence of renal and ureteric calculi in renal transplant recipients is 10 times lower compared to the general population. [1] [2] [3] [4] Isolated ureteric calculi are even rarer.
Graft dysfunction due to urolithiasis is a rare condition which can be prevented with timely intervention. The present case highlights the importance of early diagnosis and management of ureteric calculi in transplanted kidney.
Case report
A 42-year-old hypertensive male patient with end stage renal disease secondary to chronic glomerulonephritis underwent live related kidney transplantation on 28/2/05 with mother as donor. After transplantation, the patient had delayed graft function and required one session of hemodialysis in the first week of transplantation. Ultrasonography showed a normal renal allograft with normal vascularity and no hydronephrosis. The graft function recovered with serum creatinine reaching a nadir value of 1.5 mg/ dl and the patient was discharged on triple immunosuppresion (cyclosporine, prednisolone and mycophenolate mofetil). Two months later he presented with complaint of fever with chills. He had no history of oliguria or hematuria. Serum creatinine increased to 1.7 mg/dl and CMV serology (IgM) was positive. He received Ganciclovir therapy for the same and recovered with the serum creatinine returning to baseline of 1.5 mg/dl and remained at that level till 2013 during follow up. The patient was lost to follow up for 1 year. He presented in January 2014 with complaints of intermittent hematuria with graveluria. He also developed pedal edema and rise in serum creatinine to 4.2 mg/dl. Ultrasonography was done which showed moderate graft hydroureteronephrosis along with multiple ureteric calculi 3.5 cm proximal to the VUJ. NCCT abdomen was done which confirmed the ultrasonographic findings ( Figs. 1 and 2 ). He underwent graft percutaneous nephrostomy and antegrade laser ureterolithotripsy with removal of calculi and double J stent placement. The patient had postobstructive diuresis (4 l/day) and serum creatinine decreased to 3.5 but did not fall further despite the stent in situ and started rising 2 months later. Urine culture was done which was suggestive of E. coli. The patient received culture based antibiotic Urolithiasis is one of the most common conditions seen in urology practice. Renal transplantation is associated with a lower incidence of urolithiasis compared to general population. In these patients, the incidence of isolated ureteric calculi is 5-10 times lower than renal calculi. If renal and/or ureteric calculi are present in transplanted kidney, they must be attended urgently as the presentation in such patients is atypical due to lack of sympathetic innervation of the graft kidney and the condition may rapidly progress to graft dysfunction. The diagnosis of renal and upper ureteric calculi is usually made on graft ultrasonography. For mid and distal ureteric calculi, CT and MR urography are more sensitive. For nonobstructive calculi, treatment is with extracorporeal shock wave lithotripsy (ESWL) or flexible ureteroscopic removal for smaller stone burden (<1.5 cm) while obstructive calculi and larger stones are best addressed with percutaneous nephrostomy followed by percutaneous nephrolithotomy (PCNL) or ESWL or endoscopic removal.
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and repeat urine culture was sterile. The creatinine level stayed at 4.7 and USG showed no graft hydronephrosis. The patient became dialysis dependent. Double J stent was removed and left brachiocephalic arteriovenous fistula was made. Now the patient is on maintenance hemodialysis.
Discussion
Urinary tract calculi are a common entity in urology practice with a prevalence rate of upto 18.5%. 1 However, in patients with renal transplantation, the prevalence of urolithiasis is low ranging up to 1.7%. [2] [3] [4] Isolated ureteric calculi are even rarer, around 0.2%.
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The reason for this low prevalence is not clear. It has been suggested that the immunosuppressive regimen used in these patients should actually increase the risk of stone formation. Glucocorticoids predispose to stone formation in patients with Cushing's disease. 6 Likewise, calcineurin inhibitors are associated with hyperkalemia, hyperoxaluria, hypercalciuria, hyperuricosuria, hypocitraturia and hypomagnesemia and increase the risk of calculi especially those containing uric acid. 7 The low prevalence of calculi in patients with renal transplantation may be attributed to careful donor screening, early loss of concentrating ability of kidney leading to polyuria, and denervation of the graft which masks any renal or ureteric colic. 8 Most of the calculi are believed to have formed de novo in the transplanted kidney with an incidence of donor graft lithiasis around 0.64%. 9 However, Klingler et al. reported the incidence to be as high as 47%. 8 Such donor-gifted calculi can be easily detected on pretransplant ultrasonography in the donor or postoperative ultrasonography in the recipient. The presentation of urolithiasis in transplant patients differs from non transplant patients. In absence of the allograft innervations, these patients do not experience the typical colicky pain but instead have a vague lower abdominal discomfort which may be due to peritoneal irritation from a hydronephrotic collecting system. 10 Graft dysfunction as a result of urolithiasis is an unusual entity. Infact, the most common cause of obstructive uropathy after renal transplant is ureteral stenosis secondary to ischemia or rejection.
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Graft dysfunction is more commonly associated with ureteric calculi than renal calculi. Ureteric calculi are usually associated with a gradual deterioration of graft function although acute rejection secondary to donor ureteric calculi has also been reported. 12 Obstructive uropathy almost always occurs within first 6 months after transplantation. Diagnosis of proximal ureteric calculi can be reliably made on ultrasonography while mid and distal ureteric calculi are more effectively detected using CT or MR urography. 13 Management of calculi in transplanted kidney is similar to the management in patients with solitary functioning kidneys. The minimally invasive techniques are performed first. The options include ESWL, PCNL and flexible ureteroscopic removal. Patients with nonobstructive calculi up to 4-5 mm may be observed if they have no signs of impaired graft dysfunction. Such patients are kept on close follow up with monitoring of urine output and measurement of creatinine levels along with weekly ultrasonography. While fall in urine output and rise in creatinine level occur early, ultrasonographic changes take time to be established. ESWL is done in prone position and is well suited for nonobstructive calculi up to 1.5 cm. In a series by Challacombe et al., it was seen that the position of the transplant kidney does not affect stone clearance. 14 Despite the difficulties in stone localization due to overlying bony pelvis, most patients can be treated successfully in prone position. For obstructive calculi, management involves upfront PCNL or ESWL after insertion of double J stent. PCNL in transplant kidneys is done in supine position and was first described by Hulbert et al. in 1985. 15 It is the treatment of choice for large stone burden. Flexible ureteroscopy can be used for removal of smaller stone burden but it is technically challenging because of the more anterior location of the neo-ureteric orifice as well as need for a greater secondary deflection. As ureteroscopic procedures do not affect the graft function compared to PCNL, they are now being used increasingly for the management of calculi in transplanted kidney and ureter. In patients presenting with acute graft dysfunction secondary to obstructive calculi, an urgent percutaneous nephrostomy is indicated to relieve the obstruction. Further management depends on the location and number of calculi.
Conclusion
Graft dysfunction secondary to urolithiasis is rare and can be prevented easily with regular follow up and timely intervention for any rise in serum creatinine or fall in urine output.
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